Sex Cord-Gonadal Stromal Tumors - 12 Studies Found
Active, not recruiting |
: Efficacy and Safety of Bevacizumab (Avastin®) Combined to Weekly Paclitaxel Followed by Bevacizumab (Avastin®) Alone in Patients With Relapsed Ovarian Sex-cord Stromal Tumours (ALIENOR) : Ovarian Sex-cord Stromal Tumor : 2013-01-15 :
|
Enrolling by invitation |
: TC or BEP in Treating Patients With Ovarian Malignant Sex Cord-Stromal Tumors :
: |
Active, not recruiting |
: Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary :
|
Completed |
: Studying Genes in Samples From Younger Patients With Ovarian or Testicular Sex Cord Stromal Tumors :
|
Recruiting |
: Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors :
|
Completed |
: Paclitaxel in Treating Patients With Ovarian Stromal Cancer :
|
Terminated |
: Ketoconazole as Inhibitor of the Enzyme CYP17 in Locally Advanced or Disseminated Granulosa Cell Tumour of Ovary : Granulosa Cell Tumour of the Ovary : 2012-04-22 : Drug: Ketoconazole Patients will receive ketoconazole, 400 mg three times a day. Study treatment period |
Completed |
: Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer :
|
Completed |
: Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer :
|